Related Experiment Video
Updated: Aug 9, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
Published on: May 10, 2022
The ETS protein MEF is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2
Yan Liu1, Cyrus V Hedvat, Shifeng Mao
1Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 575, New York, NY 10021, USA.
Abstract:
MEF is an ETS-related transcription factor with strong transcriptional activating activity that affects hematopoietic stem cell behavior and is required for normal NK cell and NK T-cell development. The MEF (also known as ELF4) gene is repressed by several leukemia-associated fusion transcription factor proteins (PML-retinoic acid receptor alpha and AML1-ETO), but it is also activated by retroviral insertion in several cancer models. We have previously shown that cyclin A-dependent phosphorylation of MEF largely restricts its activity to the G(1) phase of the cell cycle; we now show that MEF is a short-lived protein whose expression level also peaks during late G(1) phase. Mutagenesis studies show that the rapid turnover of MEF in S phase is dependent on the specific phosphorylation of threonine 643 and serine 648 at the C terminus of MEF by cdk2 and on the Skp1/Cul1/F-box (SCF) E3 ubiquitin ligase complex SCF(Skp2), which targets MEF for ubiquitination and proteolysis. Overexpression of MEF drives cells through the G(1)/S transition, thereby promoting cell proliferation. The tight regulation of MEF levels during the cell cycle contributes to its effects on regulating cell cycle entry and cell proliferation.
Insights
MEF (ELF4) is a cell cycle-regulated transcription factor crucial for immune cell development. Its rapid degradation in S phase, controlled by specific phosphorylation and ubiquitination, ensures proper cell proliferation.
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- MEF (ELF4) is an ETS-related transcription factor impacting hematopoietic stem cell behavior and NK/NKT cell development.
- MEF gene expression is regulated by oncogenic fusion proteins and retroviral insertions.
- Previous work indicated MEF activity is restricted to G1 phase by cyclin A-dependent phosphorylation.
Purpose of the Study:
- To investigate the cell cycle regulation of MEF protein stability and its underlying molecular mechanisms.
- To determine how MEF protein levels are controlled throughout the cell cycle and impact cell proliferation.
Main Methods:
- Mutagenesis studies to identify key phosphorylation sites.
- Analysis of MEF protein turnover using ubiquitination and proteolysis assays.
- Cell cycle analysis and proliferation assays upon MEF overexpression.
Main Results:
- MEF is a short-lived protein with peak expression in late G1 phase.
- Rapid MEF turnover in S phase is mediated by cdk2 phosphorylation at T643/S648 and SCF(Skp2) ubiquitination.
- MEF overexpression accelerates the G1/S transition and promotes cell proliferation.
Conclusions:
- Tight cell cycle regulation of MEF protein levels is critical for controlling cell cycle entry and proliferation.
- The identified phosphorylation and ubiquitination pathway provides a mechanism for MEF degradation.
- Understanding MEF regulation offers insights into immune cell development and cancer biology.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Master Transcription Regulators
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

